CVS Health Aktie
WKN: 859034 / ISIN: US1266501006
|
29.10.2025 14:21:44
|
CVS Health Q3 Results Top Estimates
(RTTNews) - CVS Health Corp. (CVS) reported Wednesday a net loss attributable to the company for the third quarter of $3.98 billion or $3.13 per share, compared to net income of $87 million or $0.07 per share in the prior-year quarter.
The results for the latest quarter include a $5.7 billion goodwill impairment charge related to the Health Care Delivery reporting unit within the Health Services segment, , partially offset by a gain of $483 million on the deconsolidation of Omnicare, LLC.
Excluding items, adjusted income attributable to the company for the quarter was $2.04 billion or $1.60 per share, compared to $1.37 billion or $1.09 per share in the year-ago quarter.
On average, 24 analysts polled expected the company to report earnings of $0.96 per share for the quarter. Analysts' estimates typically exclude special items.
Total revenues for the quarter grew 7.8 percent to a record of $102.87 billion from $95.43 billion in the same quarter last year. Analysts expected revenues of $101.32 billion for the quarter.
For more earnings news, earnings calendar, and earnings for stocks, visit rttnews.com
Der finanzen.at Ratgeber für Aktien!
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu CVS Health Corpmehr Nachrichten
Analysen zu CVS Health Corpmehr Analysen
Aktien in diesem Artikel
| CVS Health Corp | 67,20 | -1,38% |
|